Patent ID: 11926665
Assignee: TESARO, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treating a lung cancer in a human subject, the method comprising: (i) administering, to the human subject, a flat dose of 300 mg, once every 3 weeks (Q3W), of an anti-TIM-3 antibody that comprises a heavy chain variable domain comprising SEQ ID NO: 1 and a light chain variable domain comprising SEQ ID NO:2; and, (ii) administering, to the human subject, an anti-Programmed Death-1 (anti-PD-1) antibody comprising a heavy chain comprising SEQ ID NO: 13 and a light chain comprising SEQ ID NO: 14, wherein the human subject has the lung cancer.